medigraphic.com
ISSN 1029-3019 (Electronic)

2014, Number 05

<< Back Next >>

MediSan 2014; 18 (05)

Impact of hemotherapy in the severely ill patient

Badell PCC, Bosch CC, Verdecia MA

Language: Spanish
References: 20
Page: 630-636
PDF size: 54.29 Kb.


ABSTRACT

A descriptive, longitudinal and prospective study of 130 severely ill patients, admitted in the Intensive Care Unit in "Dr. Juan Bruno Zayas Alfonso" Teaching General Hospital from Santiago de Cuba was carried out during the biennium 2011-2013, aimed at determining the impact of the hemotherapy on the health state of those affected, based on clinical and epidemiological aspects of interest. Patients older than 65 years, those with surgical diseases and neumopathies prevailed in the series. Among the most frequent causes and complications there were: the anemia as the first ones and the feverish non haemolytic reaction, as the second one. Late complications or mortality were not detected after the hemotherapy.


REFERENCES

  1. Santolaya ME, Rabagliati R, Bidart T, Payá E, Guzmán AM, Morales R, et al. Consenso Manejo racional del paciente con cáncer, neutropenia y fiebre. Rev Chil Infect. 2005;22(supl 2):79-113.

  2. Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp. and Aspergillus spp: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol. 2006;44(5):1782-7.

  3. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT study: anemia and blood transfusion in the critically ill. Current clinical practice in the United States. Crit Care Med. 2004;32(1):39-52.

  4. Muñoz M, Romero A, Morales M, Campos A, García-Erce JA, Ramírez G. Metabolismo del hierro, inflamación y anemia en pacientes en estado crítico: un estudio transversal. Nutr Hosp. 2005;20(2):115-20.

  5. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288(12):1499- 507.

  6. Muñoz M, Leal-Noval SR, García-Erce JA, Naveira E. Prevalencia y tratamiento de la anemia en el paciente crítico. Med Intensiva. 2007;31(7):388-98.

  7. Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, et al. Efficacy and safety of epoetin alfa in critically ill patients. New Engl J Med. 2007;357:965-76.

  8. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized, controlled trial. JAMA. 2002;288(22):2827-35.

  9. Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, et al. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study. Crit Care. 2005;9(5):508.

  10. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med. 2004;116 (Suppl 7A):58-69.

  11. Madrazo González Z, García Barrasa A, Rodríguez Lorenzo L, Rafecas Renau A, Alonso Fernández G. Actualización en anemia y terapia transfusional. Med Intensiva.2011; 35(1):32-40.

  12. Chernow B. Blood conservation in critical care-the evidence accumulates. Crit Care Med. 1993;21(4):481-2.

  13. Foulke GE, Harlow DJ. Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients. Crit Care Med. 1989;17(11):1143-5.

  14. Walker RH. Special report. Transfusion risks. Am J Clin Pathol. 1987;88(3):374-8.

  15. Friedman BA. Patterns of blood utilization by physicians: transfusion of nonoperated anemic patients. Transfusión. 1978;18(2):193-8.

  16. Serrano Trenas JA, Font Ugalde P, Muñoz Cabello L, Castro Chofles L, Serrano Lázaro P, Carpintero Benítez P. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusión. 2011;51(1):97-104.

  17. Aristizábal Linares JP. La lesión por almacenamiento y la transfusión sanguínea. Rev col antes. 2012 [citado 12 feb 2013];40(4).

  18. Jiménez Bodib JR, López Espinosa N, Hernández González O. Protocolo para el manejo eficiente de las transfusiones de concentrados de glóbulos rojos en el Servicio de Ortopedia y Traumatología del Hospital Provincial “Dr. Antonio Luaces Iraola” de Ciego de Ávila. MEDICIEGO. 2010 [citado 12 feb 2013];16(2).

  19. Álvarez Vázquez J. Transfusión de sangre. Rev Hum Med. 2008 [citado 12 feb 2013];8(2-3).

  20. Tena Tamayo C, Sánchez González JM. La transfusión sanguínea y los derechos del paciente. Revista CONAMED. 2005 [citado 12 feb 2013];10(2)




2020     |     www.medigraphic.com